Enliven Therapeutics
ELVN
#5143
Rank
ยฃ1.17 B
Marketcap
ยฃ19.87
Share price
-2.98%
Change (1 day)
9.23%
Change (1 year)

Enliven Therapeutics (ELVN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ10.86 Million

According to Enliven Therapeutics's latest financial reports the company's total liabilities are ยฃ10.86 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enliven Therapeutics - Total liabilities on balance sheet (from 2021 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ12.68 M-37.76%
2023-12-31ยฃ20.37 M-84.6%
2022-12-31ยฃ0.13 B14.37%
2021-12-31ยฃ0.11 B4.26%
2020-12-31ยฃ0.11 B